Private Advisor Group’s Corcept Therapeutics CORT Stock Holding History

Private Advisor Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Buy	+3,622	New	+$219K	﹤0.01%	2081
2025 Q4	–	Sell	-2,872	Closed	-$239K	–	2649
2025 Q3	$239K	Hold	2,872	–	–	﹤0.01%	2230
2025 Q2	$211K	Buy	2,872 +9	+0.3%	+$653	﹤0.01%	2202
2025 Q1	$327K	Buy	+2,863	New	+$174K	﹤0.01%	1820
2020 Q4	–	Sell	-11,011	Closed	-$192K	–	1784
2020 Q3	$192K	Hold	11,011	–	–	﹤0.01%	1413
2020 Q2	$185K	Sell	11,011 -10,989	-50%	-$154K	﹤0.01%	1398
2020 Q1	$262K	Sell	22,000 -3,000	-12%	-$37.1K	﹤0.01%	1132
2019 Q4	$303K	Buy	+25,000	New	+$348K	﹤0.01%	1268

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Advisor Group's CORT Position: Q2 2026 in Review

Private Advisor Group opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 3,622 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #2081 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in CORT as recently as Q3 2025.

Private Advisor Group first reported a position in CORT in Q4 2019 and has held it in 8 quarters since. The position peaked at $327K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Private Advisor Group held 3,622 shares of Corcept Therapeutics worth $315K as of Q2 2026.
Corcept Therapeutics was a new Private Advisor Group position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2081 holding.
Private Advisor Group first reported a position in Corcept Therapeutics in Q4 2019 and has held it in 8 quarters since.
Private Advisor Group's Corcept Therapeutics position peaked at $327K in Q1 2025.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.